Michael Böhm1*, MD; Felix Mahfoud1, MD; Christian Ukena1, MD; Axel Bauer2, MD; Eckart Fleck3, MD; Uta C. Hoppe4, MD; Ulrich Kintscher5, MD; Krzysztof Narkiewicz6, MD, PhD; Manuela Negoita7, MD; Luis Ruilope8, MD, PhD; L. Christian Rump9, MD; Markus Schlaich10, MD; Roland Schmieder11, MD; Horst Sievert12, MD; Joachim Weil13, MD; Bryan Williams14, MD; Uwe Zeymer15, MD; Giuseppe Mancia16, MD, PhD
1. Universitätskliniken des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, Germany; 2. Universitätsklinikum Tübingen, Innere Medizin III, Tübingen, Germany; 3. Deutsches Herzzentrum Berlin, Klinik für Innere Medizin – Kardiolo
Aims: Hypertension is a global healthcare concern associated with a wide range of comorbidities. The recognition that elevated sympathetic drive plays an important role in the pathogenesis of hypertension led to the use of re